Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Clascoterone by Cosmo Pharmaceuticals for Pancreatic Cancer: Likelihood of Approval
Clascoterone is under clinical development by Cosmo Pharmaceuticals and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
Data Insights
Clascoterone by Cosmo Pharmaceuticals for Prostate Cancer: Likelihood of Approval
Clascoterone is under clinical development by Cosmo Pharmaceuticals and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...